Market revenue in 2023 | USD 2,866.9 million |
Market revenue in 2030 | USD 8,171.4 million |
Growth rate | 16.1% (CAGR from 2023 to 2030) |
Largest segment | Injectables |
Fastest growing segment | Injectables |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Injectables, Skin Rejuvenation |
Key market players worldwide | Hologic Inc, AbbVie Inc, Galderma Group AG Registered Shares, Alma Lasers Ltd, UltraShape Ltd. (Syneron Medical), Johnson & Johnson, Merz Pharma, Lumenis, Bausch Health Companies Inc, Cutera Inc, Revance Therapeutics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-invasive aesthetic treatment market will help companies and investors design strategic landscapes.
Injectables was the largest segment with a revenue share of 62.95% in 2023. Horizon Databook has segmented the China non-invasive aesthetic treatment market based on injectables, skin rejuvenation covering the revenue growth of each sub-segment from 2018 to 2030.
Growth of non-invasive aesthetic treatment market in China can be attributed to increasing demand for antiaging and antipollution skin care products. Nearly 23% of population in China is geriatric, which is expected to boost adoption of noninvasive aesthetic treatments, leading to market growth.
The buying power of China’s growing middle-class population is increasing, and the local population is more inclined to buy quality products, making the country world’s second largest aesthetic market after the U.S. In China, the number of aesthetic and lip augmentation procedures is increasing significantly by a staggering 7.9% per year, according to the South China Morning Post.
Moreover, social media apps, such as Meitu, Instagram, WeChat, and Snapchat, have changed the way people in China perceive their appearance. In 2018, there were about 20 million medical aesthetic consumers, of which about 64% were born after 1990 and around 19% were postmillennial, according to a report by So-Young, a NASDAQ-listed online plastic surgery marketplace, in China.
Horizon Databook provides a detailed overview of country-level data and insights on the China non-invasive aesthetic treatment market , including forecasts for subscribers. This country databook contains high-level insights into China non-invasive aesthetic treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account